Benefits

ARE YOU THRIVING?

U.S. adults report frequent stress, with 76% saying it harms their health and 40% saying it disrupts their daily function (1,2,3).

1 in 2

U.S. adults do not get the recommended 7+ hours of sleep, and an estimated 50–70 million adults have a least one sleep disorder (4,5).

1 in 3

U.S. adults report feeling tired or fatigued on a regular basis with only 49% saying they feel they are “thriving” (6,7).

1 in 3

Regenesis Neuro’s evidence-based approach improves sleep, reduces stress symptoms, sustains mental clarity under pressure, and builds cognitive reserve, enabling you to thrive.


Synergistic Approach For Amplified Results

Regenesis Neuro uses low-energy neurofeedback (LENS), along with other integrated therapies: Audio-Visual Entrainment (AVE), Cranial Electrical Stimulation (CES), and Photobiomodulation (red light therapy). Each are supported by clinical research with proven results:

Reduced stress and mental fatigue

Improved attention & focus

Improved sleep quality and duration

Increased mood regulation

Increased emotional resilience

Decreased symptoms of anxiousness & depression

SESSIONS ARE:

  • Just 20 minutes

  • Non-invasive

  • Performed onsite or offsite

  • Talk-free, no active participation

  • Effective, with results often seen within three sessions (8).


Give your brain what it needs so you can function at your best.

1. Gallup, State of the Global Workplace 2024; American Institute of Stress, Stress Statistics. 2. American Psychological Association, “Stress in America™ survey, 2023”. 3. American Psychological Association, “Stress in America™ 2022–2023”. 4. NIH/NHLBI, “Sleep Deprivation and Deficiency,” 2022. 5. NIH/NHLBI and NIH MedlinePlus, sleep statistics (50–70 million with sleep disorders). 6. Freeman & Cheng,“ Demographic correlates of fatigue in the US general population,” J Psychosom Res, 2016. 7. Gallup News, “New Normal: Lower U.S. Life Ratings,” Jan 18, 2024. 8 Larsen S, Harrington K, Hicks S. The LENS (Low Energy Neurofeedback System): “A clinical outcomes study on one hundred patients at Stone Mountain Center”, New York. J Neurotherapy. 2006;10(2-3):69-78.